哌拉西林钠/他唑巴坦钠联合喹诺酮类药物治疗卒中相关性肺炎临床观察

摘要

目的：探析哌拉西林钠/他唑巴坦钠联合喹诺酮类药物治疗卒中相关性肺炎效果。方法选择2012年1月～2015年12月我院收治的卒中相关性肺炎患者83例，对照组35例选择用药头孢曲松钠（罗氏芬），治疗组48例则选择用药哌拉西林钠/他唑巴坦钠+莫西沙星，对比两组治疗临床效果。结果对照组总有效率65.71%，细菌成分清除率71.43%，治疗组分别为89.58%和87.50%，两组数据比较，差异具有统计学意义，P＜0.05。结论联合使用哌拉西林钠/他唑巴坦钠+莫西沙星治疗卒中相关性肺炎效果显著。%Objective Analysis of the effect of piperacillin/tazobactam sodium combined with quinolones in the treatment of stroke associated pneumonia. Methods From January 2012 to December 2015, 83 cases of patients with stroke associated pneumonia in our hospital were selected, 35 cases of patients in control group were treated with cephalosporins sodium, 48 cases of patients in treatment group were treated with piperacillin/tazobactam + moxifloxacin, to compare clinical effect of two groups. Results The total efifciency of control group 65.71%, the clearance rate of bacterial components was 71.43%, the treatment group was 89.58% and 87.50%, the difference was statistically significant,P<0.05.Conclusion Piperacillin / tazobactam combined with moxilfoxacin in the treatment of stroke associated pneumonia has signiifcantly effect.